About Symbiotec Pharmalab Limited
Data last updated: 21 December 2025
Symbiotec Pharmalab Limited is a public limited company based in Mhow, Madhya Pradesh, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 20 September 2002, the company has been in operation for over 24 years.
Registered with ROC Gwalior under CIN U24232MP2002PLC015293.
Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹12.34 Cr. Formerly known as Symbiotec Pharmalab Limited. It is led by directors including Rohit Brijmohan Mantri and Pratik Patel.
Last AGM: 26 September 2024. Financial statements filed for year ended 31 March 2024. Office: Mhow, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹755.98 Cr, a growth of 5% compared to the previous year.
The company has a workforce of approximately 1,330 employees as per the latest available data.
The company is associated with 1 brand - Symbiotec. As per MCA filings, the company has open charges of ₹556.47 Cr and satisfied charges of ₹395.55 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website symbiotec.in.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered Address385/2 Pigdamber, Rau, Mhow, Madhya Pradesh, India – 453331
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Symbiotec Pharmalab Limited
Symbiotec Pharmalab Limited has one previous CIN (Corporate Identification Number): U24232MP2002PTC015293. The current CIN is U24232MP2002PLC015293, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232MP2002PLC015293 | Current |
| U24232MP2002PTC015293 | Previous |
Associated Brands with Symbiotec Pharmalab Limited
Symbiotec Pharmalab Limited operates one associated brand: Symbiotec. These brands represent Symbiotec Pharmalab Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Non-sterile steroid hormone-based APIs and intermediates are manufactured. | symbiotec.in |
Competitors & Alternatives of Symbiotec Pharmalab Limited
Brands and companies operating in the same space as Symbiotec Pharmalab Limited include Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
|
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
|
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
|
|
APIs are manufactured and custom synthesis services are provided. | Somerset, United States, United States | 2004 |
|
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
|
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
|
|
APIs and intermediates are researched and manufactured, specializing in heterocycles. | Beijing, China, China | 2007 |
Business Activity of Symbiotec Pharmalab Limited
Symbiotec Pharmalab Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Symbiotec Pharmalab Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Symbiotec Pharmalab Limited
Symbiotec Pharmalab Limited is currently managed by 6 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Rohit Brijmohan Mantri
Also directs:
Symbiotec Biologics Private Limited, Symbiotec Zenfold Private Limited, Knovea Pharmaceutical Private Limited and 5 more
|
Nominee Director | 06 Dec 2018 | 7 Years 8 Months | Current |
|
Pratik Patel
Also directs:
Symbiotec Pharmalab Limited, Jash Engineering Ltd, Patamin Investments Private Limited and 3 more
|
Director | 16 Dec 2025 | 0 Years 8 Months | Current |
|
Buggana Hariharnath
Also directs:
Symbiotec Zenfold Private Limited, Knovea Pharmaceutical Private Limited, Symbiotec Pharmalab Limited and 5 more
|
Nominee Director | 16 Sep 2024 | 1 Years 11 Months | Current |
|
Sunita Kishnani
Also directs:
Symbiotec Pharmalab Limited, Jash Engineering Ltd
|
Director | 27 Nov 2025 | 0 Years 8 Months | Current |
| Anil Kumar Satwani | Officer In Default | 14 May 2005 | 21 Years 3 Months | Current |
|
Richard Patrick Findlay Kenny
Also directs:
Symbiotec Pharmalab Limited
|
Director | 27 Nov 2025 | 0 Years 8 Months | Current |
Financials of Symbiotec Pharmalab Limited FY 2024 filings available
Symbiotec Pharmalab Limited reported revenue of ₹755.98 Cr (up 5.00% YoY) for FY 2025.
Ten-year financial statements for Symbiotec Pharmalab Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Symbiotec Pharmalab Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2025 | State Bank of India | ₹25,000 | Open |
| 27 Sep 2024 | Sbicap Trustee Company Limited | ₹555.98 Cr | Open |
| 06 Feb 2019 | Yes Bank Limited | ₹49 Lakh | Open |
| 28 Jul 2022 | Axis Bank Limited | ₹1.99 Cr | Satisfied |
| 01 Mar 2018 | Hdfc Bank Limited | ₹1.25 Cr | Satisfied |
Total charge records: 18 View all charges
Employees and EPFO Compliance at Symbiotec Pharmalab Limited
View historical data on people associated with Symbiotec Pharmalab Limited, including employment history and EPFO contributions.
Employee and EPFO history for Symbiotec Pharmalab Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Symbiotec Pharmalab Limited
GST registrations and filing compliance for Symbiotec Pharmalab Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Symbiotec Pharmalab Limited
Credit ratings, litigation, and regulatory alerts for Symbiotec Pharmalab Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Symbiotec Pharmalab Limited
MSME payment history for Symbiotec Pharmalab Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Symbiotec Pharmalab Limited
Corporate group structure for Symbiotec Pharmalab Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Symbiotec Pharmalab Limited
MCA filings and documents for Symbiotec Pharmalab Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Symbiotec Pharmalab Limited
Recent News on Symbiotec Pharmalab Limited
Frequently Asked Questions about Symbiotec Pharmalab Limited
Symbiotec Pharmalab Limited is an active public limited company in the pharma sector based in Mhow, Madhya Pradesh, India. It was incorporated on 20 September 2002 (24+ years old) and is registered under CIN U24232MP2002PLC015293. The company has 1,330 employees.
Symbiotec Pharmalab Limited reported revenue of ₹755.98 Cr for FY 2025 (up 5.00% YoY).
The current directors of Symbiotec Pharmalab Limited are:
- Rohit Brijmohan Mantri - Nominee Director
- Pratik Patel - Director
- Buggana Hariharnath - Nominee Director
- Sunita Kishnani - Director
- Anil Kumar Satwani - Officer In Default
- Richard Patrick Findlay Kenny - Director
The primary industry of Symbiotec Pharmalab Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Symbiotec Pharmalab Limited can be reached at the registered office: 3852 Pigdamber, Rau, Mhow, Madhya Pradesh, India – 453331, or through the website symbiotec.in.
The authorised capital is ₹30 Cr, and the paid-up capital is ₹12.34 Cr.